Dr. Reddy’s and Hetero to Roll Out Affordable $40-per-Year Generic HIV Prevention Injection by 2027, Making Twice-Yearly Lenacapavir Accessible Across 120 Low- and Middle-Income Countries in Partnership with Global Health Agencies